Agenda I status definitely enhances the volume of complexity for any study study. As an example, all scientists—regardless of whether preclinical or clinical—need to receive Agenda I analysis registrations. 21 CFR portion 1301.18. Against this, scientists that have DEA Practitioner registrations in Schedules II–V (which most physicians might